AI assistant
PFIZER INC — Director's Dealing 2020
Feb 29, 2020
29831_dirs_2020-02-28_c4e8f0c2-2e4f-4e29-ace8-3a4841c95a30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-26
Reporting Person: GOETTLER MICHAEL (Group President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-26 | Common Stock | M | 20129.0000 | $34.5900 | Acquired | 45557.0000 | Direct |
| 2020-02-26 | Common Stock | A | 3164.0000 | $0.0000 | Acquired | 48721.0000 | Direct |
| 2020-02-26 | Common Stock | F | 1266.0000 | $34.7200 | Disposed | 47455.0000 | Direct |
| 2020-02-26 | Common Stock | F | 1906.0000 | $34.7200 | Disposed | 45549.0000 | Direct |
| 2020-02-26 | Common Stock | F | 15365.0000 | $36.8000 | Disposed | 30184.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-26 | Stock Appreciation Rights | $34.5900 | M | 20129.0000 | Disposed | 2020-02-26 | Common Stock (20129.0000) | Direct |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
F4: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F5: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F6: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.